A new trading day began on November 20, 2023, with Tarsus Pharmaceuticals Inc (NASDAQ: TARS) stock priced at $18.44, down -7.21% from the previous day of trading. During the day, the shares moved up to $18.75 and dropped to $17.49 before settling in for the closing price of $18.86. TARS’s price has ranged from $11.33 to $25.25 over the past 52 weeks.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -13.68%. Meanwhile, its annual earnings per share averaged -89.81%. With a float of $21.93 million, this company’s outstanding shares have now reached $26.73 million.
The extent of productivity of a business whose workforce counts for 87 workers is very important to gauge. In terms of profitability, gross margin is +96.30, operating margin of -242.92, and the pretax margin is -240.53.
Tarsus Pharmaceuticals Inc (TARS) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tarsus Pharmaceuticals Inc is 33.75%, while institutional ownership is 71.42%. The most recent insider transaction that took place on Nov 15, was worth 146,933. In this transaction President/CEO and Board Chair of this company sold 8,000 shares at a rate of $18.37, taking the stock ownership to the 878,106 shares. Before that another transaction happened on Oct 18, when Company’s President/CEO and Board Chair sold 8,000 for $13.24, making the entire transaction worth $105,920. This insider now owns 886,106 shares in total.
Tarsus Pharmaceuticals Inc (TARS) Performance Highlights and Predictions
In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$1.28 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -240.51 while generating a return on equity of -34.53. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -89.81% per share during the next fiscal year.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Trading Performance Indicators
Here are Tarsus Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 40.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.83, a number that is poised to hit -1.37 in the next quarter and is forecasted to reach -4.91 in one year’s time.
Technical Analysis of Tarsus Pharmaceuticals Inc (TARS)
The latest stats from [Tarsus Pharmaceuticals Inc, TARS] show that its last 5-days average volume of 0.75 million was superior to 0.3 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 66.15%. Additionally, its Average True Range was 1.11.
During the past 100 days, Tarsus Pharmaceuticals Inc’s (TARS) raw stochastic average was set at 38.88%, which indicates a significant decrease from 66.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 78.37% in the past 14 days, which was lower than the 89.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.81, while its 200-day Moving Average is $16.10. Now, the first resistance to watch is $18.34. This is followed by the second major resistance level at $19.17. The third major resistance level sits at $19.60. If the price goes on to break the first support level at $17.08, it is likely to go to the next support level at $16.65. Assuming the price breaks the second support level, the third support level stands at $15.82.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Key Stats
With a market capitalization of 579.25 million, the company has a total of 33,105K Shares Outstanding. Currently, annual sales are 25,820 K while annual income is -62,090 K. The company’s previous quarter sales were 1,870 K while its latest quarter income was -39,150 K.